Danaher (DHR) Beats Q4 Earnings and Revenue Estimates

Core Viewpoint - Danaher (DHR) reported quarterly earnings of $2.23 per share, exceeding the Zacks Consensus Estimate of $2.22 per share, and showing an increase from $2.14 per share a year ago, indicating a positive earnings surprise of +0.68% [1] Financial Performance - The company achieved revenues of $6.84 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.64% and up from $6.54 billion year-over-year [2] - Over the last four quarters, Danaher has consistently exceeded consensus EPS estimates and revenue estimates [2] Stock Performance - Danaher shares have increased approximately 3% since the beginning of the year, outperforming the S&P 500, which gained 1.9% [3] Future Outlook - The company's earnings outlook will be crucial for assessing future stock performance, with current consensus EPS estimates at $2.00 for the upcoming quarter and $8.42 for the current fiscal year [4][7] - The Zacks Rank for Danaher is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Medical Services industry, to which Danaher belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, which may impact stock performance [8] - Another company in the same industry, Teladoc (TDOC), is expected to report a quarterly loss of $0.19 per share, reflecting a year-over-year change of +32.1% [9]